Paper38136193
N-Acetylcysteine and Atherosclerosis: Promises and Challenges.
Cui Y and 4 others. Antioxidants (Basel), 2023. Cited by 22 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. N-Acetylcysteine and Atherosclerosis: Promises and Challenges. Papers, record 38136193. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136193
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL148196 | NHLBI NIH HHS | United States | R01HL148196 | PubMed | NIH RePORTER |
| RF1 NS132279 | NINDS NIH HHS | United States | RF1NS132279 | PubMed | NIH RePORTER |
References145
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14668186 | N-acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients. | Scand Cardiovasc J | 2003 | https://conductscience.org/library/papers/14668186 | PubMed |
| 2 | 26085187 | N-acetylcysteine Plus Deferoxamine Improves Cardiac Function in Wistar Rats After Non-reperfused Acute Myocardial Infarction. | J Cardiovasc Transl Res | 2015 | https://conductscience.org/library/papers/26085187 | PubMed |
| 3 | 18474268 | Why have antioxidants failed in clinical trials? | Am J Cardiol | 2008 | https://conductscience.org/library/papers/18474268 | PubMed |
| 4 | 33380301 | The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. | Curr Neuropharmacol | 2021 | https://conductscience.org/library/papers/33380301 | PubMed |
| 5 | 25957927 | Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. | Neurosci Biobehav Rev | 2015 | https://conductscience.org/library/papers/25957927 | PubMed |
| 6 | 11561065 | N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis. | J Pharmacol Exp Ther | 2001 | https://conductscience.org/library/papers/11561065 | PubMed |
| 7 | 8836257 | Reduction of ischemia-reperfusion syndrome after abdominal aortic aneurysmectomy by N-acetylcysteine but not mannitol. | Acta Anaesthesiol Scand | 1996 | https://conductscience.org/library/papers/8836257 | PubMed |
| 8 | 11669166 | Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. | J Rheumatol | 2001 | https://conductscience.org/library/papers/11669166 | PubMed |
| 9 | 25339958 | Macrophage cytokines: involvement in immunity and infectious diseases. | Front Immunol | 2014 | https://conductscience.org/library/papers/25339958 | PubMed |
| 10 | 30045259 | Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30045259 | PubMed |
| 11 | 3127076 | Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. | Circulation | 1988 | https://conductscience.org/library/papers/3127076 | PubMed |
| 12 | 8958220 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8958220 | PubMed |
| 13 | 16427861 | Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. | Ann Thorac Surg | 2006 | https://conductscience.org/library/papers/16427861 | PubMed |
| 14 | 29284736 | Carotid Atheroma From Men Has Significantly Higher Levels of Inflammation and Iron Metabolism Enabled by Macrophages. | Stroke | 2018 | https://conductscience.org/library/papers/29284736 | PubMed |
| 15 | 36555285 | microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555285 | PubMed |
| 16 | 10476588 | Use of N-acetylcysteine in the management of coronary artery diseases. | Cardiologia | 1999 | https://conductscience.org/library/papers/10476588 | PubMed |
| 17 | 30165472 | Low Intake of Vitamin E Accelerates Cellular Aging in Patients With Established Cardiovascular Disease: The CORDIOPREV Study. | J Gerontol A Biol Sci Med Sci | 2019 | https://conductscience.org/library/papers/30165472 | PubMed |
| 18 | 23843692 | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. | Drug Des Devel Ther | 2013 | https://conductscience.org/library/papers/23843692 | PubMed |
| 19 | 22064431 | Atherosclerosis: current pathogenesis and therapeutic options. | Nat Med | 2011 | https://conductscience.org/library/papers/22064431 | PubMed |
| 20 | 34088867 | Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34088867 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42200378 | The role of miRNA in modulating oxidative stress in preeclampsia: current knowledge. | RNA Biol | 2026 | https://conductscience.org/library/papers/42200378 | PubMed |
| 41158731 | Acute blood loss anemia aggravates endothelial dysfunction after acute myocardial infarction. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41158731 | PubMed |
| 41149623 | Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine. | Metabolites | 2025 | https://conductscience.org/library/papers/41149623 | PubMed |
| 41020442 | Redox Regulation of Microvascular Physiology and Pathophysiology: Insights into Therapeutic Strategies and Limitations. | Antioxid Redox Signal | 2025 | https://conductscience.org/library/papers/41020442 | PubMed |
| 40495031 | Not 'Inactive' After All: Cardiotoxic Mechanisms of Catecholamine Metabolism by Monoamine Oxidase. | Cardiovasc Toxicol | 2025 | https://conductscience.org/library/papers/40495031 | PubMed |
| 39171325 | Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39171325 | PubMed |
| 38766817 | A Comprehensive Review on the Significance of Cysteine in Various Metabolic Disorders; Particularly CVD, Diabetes, Renal Dysfunction, and Ischemic Stroke. | Curr Protein Pept Sci | 2024 | https://conductscience.org/library/papers/38766817 | PubMed |
| 38592348 | A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592348 | PubMed |
| 38397830 | Reactive Carbonyl Species and Protein Lipoxidation in Atherogenesis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38397830 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136193
GET https://conductscience.org/api/papers/v1/38136193/references?page=2